Pharmaceuticals
Targeted Protein Degradation for CNS
#_EVENTSTARTDATE
16 Jan - 18 Jan 2024, 9:00 am - 4:45 pm
Following proof of concept in oncology, misfolded and aggregated pathological proteins across CNS indications are the new frontier for...
3rd mRNA-Based Therapeutics Summit Europe | Berlin, Germany | 23rd-25th January 2024
#_EVENTSTARTDATE
23 Jan - 25 Jan 2024, 9:00 am - 5:00 pm
The eagerly anticipated mRNA-Based Therapeutics Summit Europe returns to Berlin this January for the third year as Europe's largest...
Gene Therapy Regulatory Affairs
#_EVENTSTARTDATE
23 Jan - 25 Jan 2024, 9:00 am - 3:30 pm
With 2023 welcoming newly FDA-approved gene therapies from BioMarin, Krystal Biotech and Sarepta Therapeutics, many more treatments are hot...
7th DDR Inhibitors Summit
#_EVENTSTARTDATE
30 Jan - 01 Feb 2024, 8:30 am - 5:00 pm
DDR inhibitor development is evolving rapidly, marked by the continuous emergence of new targets. AstraZeneca and Merck reaffirm their...
2nd Panhellenic Congress of Ethnopharmacology
#_EVENTSTARTDATE
01 Mar - 03 Mar 2024, 8:00 am - 8:00 pm
We have the pleasure to announce and to invite you to the 2nd Panhellenic Congress of Ethnopharmacology, under the...
GCPRs Targeted Drug Discovery Summit
#_EVENTSTARTDATE
05 Mar - 07 Mar 2024, 8:00 am - 5:00 pm
GPCRs-targeted drug discovery continues to gain exponential momentum, with advances in screening tools, characterization of dynamic confirmations and basic...
The 9th Annual Translational Microbiome Conference
#_EVENTSTARTDATE
25 Mar - 26 Mar 2024, 8:00 am - 3:00 pm
This conference will continue to focus and build on the challenges and hurdles that companies working in the microbiome...
TOXIFORUM2024
#_EVENTSTARTDATE
11 Apr - 13 Apr 2024, 10:00 pm - 6:00 pm
It is with great pleasure that we welcome all the researchers in the field of Toxicology and Pharmacology to...
Reuters Events: Pharma 2024, Spain
#_EVENTSTARTDATE
16 Apr - 18 Apr 2024, 9:00 am - 5:00 pm
Pharma's role within the healthcare system is weakening. Increased demand, economic strains, suffocating regulatory change and a widening access...